18 min listen
Advances in CAR T-cell therapies for lymphoma from ASH 2020
FromVJHemOnc Podcast
ratings:
Length:
13 minutes
Released:
Jan 18, 2021
Format:
Podcast episode
Description
Lymphoma is a group of malignant neoplasms of lymphocytes that progress in the lymphatic system. Generally, lymphomas are categorized into...
The post Advances in CAR T-cell therapies for lymphoma from ASH 2020 appeared first on VJHemOnc.
The post Advances in CAR T-cell therapies for lymphoma from ASH 2020 appeared first on VJHemOnc.
Released:
Jan 18, 2021
Format:
Podcast episode
Titles in the series (100)
MRD testing in multiple myeloma: new technology with promising clinical applications: Determining measurable residual disease (MRD) status is undoubtedly proving to be an effective method of prognostication and measurement of response... by VJHemOnc Podcast